Market revenue in 2023 | USD 375.4 million |
Market revenue in 2030 | USD 592.2 million |
Growth rate | 6.7% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Plaque Modification Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 19.07% in 2023. Horizon Databook has segmented the France peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
The peripheral vascular devices market in France is witnessing intense competition, characterized by the active participation of multinational enterprises and specialized entities striving for market dominance. Key players in the market include Abbott, Boston Scientific Corporation, Cook Medical, Medtronic, and Terumo Corporation. Industry key players are involved in mergers & acquisitions to expand their product portfolios, which further contributes to market growth.
For instance, in October 2023, Cordis successfully finalized the acquisition of MedAlliance, a Swiss firm specializing in the development of drug-eluting balloon technology. This strategic acquisition enhances Cordis' growth prospects in both the coronary and peripheral vascular sectors.
Anticipated as the pioneering Sirolimus Drug-Eluting Balloon (DEB) to reach key markets, SELUTION SLR (Sustained Limus Release) DEB is a pivotal addition to the company's portfolio. Such initiatives are expected to boost the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the France peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into France peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account